Stay updated on Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added AA amyloidosis and multiple myeloma as related disease terms and included the Genetic and Rare Diseases Information Center as a resource.
    Difference
    0.2%
    Check dated 2026-04-03T05:47:06.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T23:49:02.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T20:29:26.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.1 to v3.4.2; no changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:01:47.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and replaced the previous v3.4.0, representing a metadata/version update without changes to the study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T00:35:30.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Added a glossary display and updated QC metadata labels (e.g., Last Update Submitted that Met QC Criteria) along with a new revision note (v3.4.0), replacing prior wording (v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T21:13:11.000Z thumbnail image

Stay in the know with updates to Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial page.